Abstract

Nodular regenerative hyperplasia (NRH) is an uncommon condition, but an important cause of noncirrhotic intrahepatic portal hypertension (NCIPH), characterized by micronodules of regenerative hepatocytes throughout the liver without intervening fibrous septae. Herein, we present a case of a thirty-seven-year-old female with systemic lupus erythematosus (SLE) who was discovered to have significant esophageal varices on endoscopy for dyspepsia. Her labs revealed a slight elevation in the alkaline phosphatase and mild thrombocytopenia. Abdominal MRI revealed seven focal hepatic masses, splenomegaly, no ascites, and a patent portal vein. Ultrasound-guided core biopsy was reported as focal nodular hyperplasia. However, her varices persisted despite treatment with beta-blockers and four additional upper endoscopies with banding. She was subsequently referred for a surgical opinion. At that time, given her history of SLE, azathioprine use, and portal hypertension, suspicion for NRH was raised. Given her normal synthetic function and lack of parenchymal liver disease, the patient was offered surgical shunting. During shunt surgery, a liver wedge biopsy was also performed and this confirmed NRH. An upper endoscopy six weeks after shunting verified complete resolution of varices. Currently, fifteen months after surgery duplex ultrasonography demonstrates shunt patency and the patient is without recurrence of her portal hypertension.

Highlights

  • Nodular regenerative hyperplasia (NRH) is a rare cause of noncirrhotic portal hypertension, with an incidence in autopsy studies of 0.5–2.6% [1, 2]

  • Symptomatic patients present with evidence of increased portal venous pressure in the absence of documented parenchymal liver disease or portal vein thrombosis

  • This paper describes a case report of NRH that presented with advanced esophageal varices and portal gastropathy that did not respond to medical management

Read more

Summary

Introduction

Nodular regenerative hyperplasia (NRH) is a rare cause of noncirrhotic portal hypertension, with an incidence in autopsy studies of 0.5–2.6% [1, 2]. The first case of NRH was described by Ranstrom in 1953 in a patient with Felty’s syndrome [3], but it was Steiner who coined the phrase “nodular regenerative hyperplasia” in 1959 [4]. NRH is usually associated with collagen vascular diseases, azathioprine (AZA) use, antiretroviral therapy in human immunodeficiency virus (HIV) treatment, and postchemotherapy especially with the use of oxaliplatin [5,6,7,8,9,10]. This paper describes a case report of NRH that presented with advanced esophageal varices and portal gastropathy that did not respond to medical management. The patient underwent nonselective portacaval shunting with resolution of her esophageal varices by six weeks postoperatively

Case Report
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call